InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,460.48
(
-0.41%
)
US TECH 100
19,180.40
(
-0.44%
)
Dow Jones
39,118.86
(
-0.12%
)
Brent Oil
84.85
(
-0.66%
)
Bitcoin
60,231.63
(
-2.24%
)
Post# of 252426
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

BTH

Send PM Follow Ignore
Followers 16
Posts 4145
Boards Moderated 1
Alias Born 06/11/2010

BTH

Re: RockRat post# 123407

Friday, 07/15/2011 10:51:35 AM

Friday, July 15, 2011 10:51:35 AM

Post# of 252426
Maybe that's the problem with Ariad's Ridaforolimus and the "sweet" zero pace of Merck's NDA filing... Merck can't figure out a brand name and every single one they choose sounds too much like Afinitor. Merck's executives probably established a 50 person blue ribbon panel to choose a name which has to go through several different committees.


>:O(
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up